Global Pharmaceutical Polymer Vials Market, By Neck Type (Crimp Neck, Double Chamber, Screw Neck, Flip Cap and Others), Cap Size (13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM and Others), Distribution Channel (Direct Sales, Medical Stores/Pharmacies, E-Commerce and Others), Capacity (1 ML, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML and Others), Drug Type (Injectable and Non-Injectable), Application (Nasal, Oral and Others), End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development and Manufacturing Companies, Compound Pharmacy and Others), Market (Parenteral, Gastro, ENT and Others) Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights : Global Pharmaceutical Polymer Vials Market
Data Bridge Market Research analyses that the pharmaceutical polymer vials market will project a CAGR of 8.5% for the forecast period of 2022-2029 and is likely to reach 4,376.09 million by 2029.
Pharmaceutical vials are used in pharmaceutical companies, biopharmaceutical companies, compound pharmacy and among several other places with the aim to enhance the shelf life in the final products.
More consumption in parenteral processing will increase the consumption of pharmaceutical vials products which will drive the market of pharmaceutical polymer vials market. Furthermore, The increasing demand for ready-to use glass vials for flexible aseptic filling are gaining prevalence among the researchers due to which the demand for pharmaceutical vials in the global pharmaceutical vials market is increasing at a higher rate are also expected to drive the growth of the pharmaceutical polymer vials market. However, chemicals release of the internal surface of glass tubing containers can restrains the pharmaceutical polymer vials market, whereas, increasing cost of overall packaging will challenge market growth of pharmaceutical polymer vials market
- In addition, increasing demand of packaging of COVID-19 vaccines will create ample opportunities for the pharmaceutical polymer vials market.
This pharmaceutical polymer vials market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on pharmaceutical polymer vials market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Pharmaceutical Polymer Vials Market Scope and Market Size
Global pharmaceutical polymer vials market is segmented on the basis of neck type, cap size, distribution channel, capacity, drug type, application, end-user and market. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of material, the pharmaceutical vials market is segmented into plastic, glass and others.
- On the basis of neck type, the pharmaceutical vials market is segmented into crimp neck, double chamber, screw neck, flip cap and others.
- On the basis of cap size, the pharmaceutical vials market is segmented into 13-425 MM, 15-425 MM, 18-400 MM, 22-350 MM, 24-400 MM, 8-425 MM, 9MM and others.
- On the basis of distribution channel, the pharmaceutical vials market is segmented into direct sales, medical stores/pharmacies, e-commerce and others.
- On the basis of capacity, the pharmaceutical vials market is segmented into 1 ML, 2 ML, 3 ML, 4 ML, 8 ML, 10 ML, 20 ML, 30 ML, 50 ML and others.
- On the basis of drug type, the pharmaceutical vials market is segmented into injectable and non-injectable.
- On the basis of application, the pharmaceutical vials market is segmented into nasal, oral, injectable and others.
- On the basis of end-user, the pharmaceutical vials market is segmented into pharmaceutical companies, biopharmaceutical companies, contract development and manufacturing companies, compound pharmacy and others.
Pharmaceutical Polymer Vials Market Country Level Analysis
The global pharmaceutical polymer vials market is analysed and market size insights and trends are provided by country, neck type, cap size, distribution channel, capacity, drug type, application, end-user and market as referenced above.
The countries covered in the pharmaceutical polymer vials market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the pharmaceutical polymer vials market and will continue to flourish its trend of dominance during the forecast period owing to the because of increasing business expansion and awareness among the customers for pharmaceutical vials. Asia-Pacific is expected to register the highest CAGR in the forecast period of 2022 to 2029 because consumer will more prefer latest design in the region.
The country section of the pharmaceutical polymer vials market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Pharmaceutical Polymer Vials Market Share Analysis
The pharmaceutical polymer vials market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to pharmaceutical polymer vials market.
Some of major players operating in the pharmaceutical polymer vials market report Bormioli Pharma S.p.a., TOYOBO CO., LTD., NIPRO, Piramal Glass Private Limited (a subsidiary of Piramal Enterprises Ltd.), Corning Incorporated, DWK Life Sciences Ltd., APG, Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services, Inc., Origin Pharma Packaging, SGD, Pacific Vial and Stevanato Group among other.
SKU-